.Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IA01_Technetium99mtcAnticarcinoembryo.Technetium99mtcAnticarcinoembryo .Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IA01_Technetium99mtcAnticarcinoembryo.Technetium99mtcAnticarcinoembryo| name: | Technetium99mtcAnticarcinoembryonicantigenAntibody |
| ATC code: | V09IA01 | route: | intravenous |
| n-compartments | 2 |
Technetium (99mTc) antiCarcinoEmbryonicAntigen antibody is a radiolabeled monoclonal antibody used in the diagnosis and imaging of tumors expressing the carcinoembryonic antigen (CEA), such as certain colorectal, medullary thyroid, and other adenocarcinomas. It is administered as a radiopharmaceutical agent for tumor localization using nuclear medicine techniques. Its clinical use is limited and not widespread today, with most imaging procedures replaced by more advanced PET/CT agents.
Pharmacokinetic parameter estimates for technetium (99mTc) antiCEA antibody based on typical monoclonal antibody behavior in adults. No published primary PK values are available; these values are estimated from analogous radiolabeled antibody agents and general principles.